Skip to main content

Table 3 Information of failed second-stage revisions

From: The proper timing of second-stage revision in treating periprosthetic knee infection: reliable indicators and risk factors

Number Gender Age BMI Diagnosis Pathogen Spacer retention period (weeks) Failed details Ending
4 Male 67 22.4 OA MRSE 24 Sinus recurrence 9 months after spacer implanted Three spacer implantations, one I&D, infection controlled.
16 Male 75 17.8 OA MRSA 12 Sinus recurrence 6 months after prosthesis implanted Two I&D and insert exchange, fusion
18 Female 65 27.7 OA Enterococcus faecalis 12 Reinfection 39 months after new prosthesis implanted Another one-stage revision, infection controlled
23 Female 56 26.6 OA Group G Streptococcus 24 Infection persist 2 months after spacer implanted Two spacer implantation, Two I&D and insert exchange, infection controlled
29 Female 63 23.9 RA Candida albicans 48 Infection persist 16 months after spacer implanted Two spacer implantation, infection controlled
30 Female 59 28.9 OA MRSE 20 Reinfection 24 months after prosthesis implanted Another one-stage revision, infection controlled
32 Male 64 22.5 OA NTM 24 Infection persist 9 months after spacer implanted Three spacer implantations, infection controlled.
35 Female 58 31.3 OA Candida albicans 40 Sinus recurrence 6 months after prosthesis implanted One I&D and insert exchange, infection controlled
37 Male 63 34.3 OA NTM 24 Infection persist 10 months after spacer implanted Three time spacer implantations, infection controlled
57 Male 54 28.7 OA Candida parapsilosis 16 Reinfection 4 months after prosthesis implanted One I&D and insert exchange, infection controlled
  1. MRSA methicillin-resistant Staphylococcus aureus, MRSE methicillin-resistant Staphylococcus epidermidis, NTM non-tuberculosis mycobacterium, I&D irrigation and debridement